These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 11783457)

  • 1. Effects of common ophthalmic preservatives on ocular health.
    Noecker R
    Adv Ther; 2001; 18(5):205-15. PubMed ID: 11783457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma.
    Baudouin C
    Acta Ophthalmol; 2008 Nov; 86(7):716-26. PubMed ID: 18537937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic Keratoconjunctivitis.
    Paley GL; Lubniewski AJ; Reidy JJ; Farooq AV
    Eye Contact Lens; 2018 Sep; 44 Suppl 1():S8-S15. PubMed ID: 28445208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular benzalkonium chloride exposure: problems and solutions.
    Goldstein MH; Silva FQ; Blender N; Tran T; Vantipalli S
    Eye (Lond); 2022 Feb; 36(2):361-368. PubMed ID: 34262161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservatives in glaucoma medication.
    Steven DW; Alaghband P; Lim KS
    Br J Ophthalmol; 2018 Nov; 102(11):1497-1503. PubMed ID: 29973365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular preservatives: associated risks and newer options.
    Kaur IP; Lal S; Rana C; Kakkar S; Singh H
    Cutan Ocul Toxicol; 2009; 28(3):93-103. PubMed ID: 19505226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of Benzalkonium Chloride in Ophthalmic Eyedrop Medications on Corneal Epithelium].
    Seino S; Takada Y; Saika S
    Yakugaku Zasshi; 2021; 141(1):35-39. PubMed ID: 33390445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preservatives in ophthalmology].
    Messmer EM
    Ophthalmologe; 2012 Nov; 109(11):1064-70. PubMed ID: 23179809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjunctiva-associated lymphoid tissue (CALT) reactions to antiglaucoma prostaglandins with or without BAK-preservative in rabbit acute toxicity study.
    Liang H; Baudouin C; Labbe A; Riancho L; Brignole-Baudouin F
    PLoS One; 2012; 7(3):e33913. PubMed ID: 22442734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzalkonium chloride in glaucoma medications.
    Noecker R; Miller KV
    Ocul Surf; 2011 Jul; 9(3):159-62. PubMed ID: 21791190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative cytotoxicity of preservatives evaluated in cell culture with Chang's human conjunctival cells--effect of temperature on cytotoxicity.
    Takahashi N
    Jpn J Ophthalmol; 1982; 26(2):234-8. PubMed ID: 7131932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
    Ammar DA; Noecker RJ; Kahook MY
    Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservatives in eyedrops: the good, the bad and the ugly.
    Baudouin C; Labbé A; Liang H; Pauly A; Brignole-Baudouin F
    Prog Retin Eye Res; 2010 Jul; 29(4):312-34. PubMed ID: 20302969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxicity research status of benzalkonium chloride on ocular surface].
    Huang C; Chen W; Chen Y; Liu Z
    Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):303-6. PubMed ID: 24931157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-hydroxymethylglycinate with EDTA is an efficient eye drop preservative with very low toxicity: an in vitro comparative study.
    Cristaldi M; Olivieri M; Lupo G; Anfuso CD; Pezzino S; Rusciano D
    Cutan Ocul Toxicol; 2018 Mar; 37(1):71-76. PubMed ID: 28658977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells.
    Epstein SP; Ahdoot M; Marcus E; Asbell PA
    J Ocul Pharmacol Ther; 2009 Apr; 25(2):113-9. PubMed ID: 19284328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic endothelial degeneration in ocular surface disease treated with topical medications containing benzalkonium chloride.
    Lemp MA; Zimmerman LE
    Am J Ophthalmol; 1988 Jun; 105(6):670-3. PubMed ID: 3287942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral drug-induced ocular pseudopemphigoid.
    Gibran SK
    Eye (Lond); 2004 Dec; 18(12):1270. PubMed ID: 15044940
    [No Abstract]   [Full Text] [Related]  

  • 19. Bandage lenses and the use of topical solutions containing preservatives.
    Lemp MA
    Ann Ophthalmol; 1978 Oct; 10(10):1319-21. PubMed ID: 718037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease.
    Goldberg I; Graham SL; Crowston JG; d'Mellow G;
    Clin Exp Ophthalmol; 2015 Apr; 43(3):214-20. PubMed ID: 25196488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.